Finnish Ecologist Clinches Crafoord Prize

This year’s Crafoord Prize has gone to Finnish ecologist Ilkka Hanski of the University of Helsinki for his contributions to understanding the impact of habitat fragmentation on species’ survival. Although Hanski has spent much of his time as a field biologist in remote regions of places such as Borneo, Greenland, and Madagascar, the prize was awarded specifically for his development of an array of mathematical models in ecology that have had great bearing on how conservationists manage natural environments.

“Hanski is the leading ecologist of his generation; he has transformed the way we understand how ecological processes work in real landscapes,” says evolutionary biologist Charles Godfray of the University of Oxford in the United Kingdom.

Hanski has spent much of his 30-year career assessing the risk of local extinctions in environments subject to growing human influence. (Here’s a link to his Web site.) In particular, he has studied the impact of habitat fragmentation on the Glanville Fritillary (Melitaea cinxia), a European butterfly that has been declining in number over the past few decades. Hanski thanks his wife for some of his success, noting she gave him a book on Finnish butterflies for his birthday many years ago. Without this book, Hanski says, he might not have stumbled over the Glanville Fritillary, which turned out to be a perfect animal with which to examine habitat fragmentation.

The Crafoord Prize, begun 29 years ago by Anna-Greta and Holger Crafoord to honor fields that are not covered by the Nobels—alternating each year between astronomy, mathematics, geosciences, and biosciences—will be awarded in May to Hanski in Stockholm by The Royal Swedish Academy of Sciences.

Hanski says that winning the Crafoord Prize is the biggest recognition that he can imagine getting. “It shows that it is possible to do good science in small countries,” he adds. Hanski was out for dinner with a colleague when the news came, and his wife sent his son running around the local restaurants to find him and fetch him to the house, where he learned of the award over the phone. Hanski says he has not yet decided what he will do with the 4 million kroners (approximately $600,000) that comes with the prize, but he suspects that he will buy a plot of forest in Finland to save it from future development.

:: Read original here ::

London Superlab Gets Local Approval

LONDON—Plans to build a £500 million medical research institute in the heart of London were approved yesterday by the key local development committee overseeing the location. The U.K. government hopes that the mammoth lab facility, construction of which should begin in the spring, will keep Britain at the forefront of global biomedical research. The approval by the Camden Town Council panel, on an 8-4 vote (with one abstention), came despite scores of registered objections, mostly by local people concerned about the loss of prime real estate previously earmarked for affordable housing.

The new facility, dubbed the UK Centre for Medical Research and Innovation (UKCMRI), will have the capacity to house 1500 staff including 1250 scientists, and it is hoped that it will attract many early-career doctors, nurses, biologists, mathematicians, physicists, chemists, computer scientists, and engineers seeking to work in a multidisciplinary institution. The four founding research organizations behind the new center—the Medical Research Council (MRC), Wellcome Trust, Cancer Research UK (CRUK), and University College London—have all contributed substantially to the funding of the building, with both MRC’s National Institute for Medical Research and CRUK’s London Research Institute intending to close their existing facilities and sell off the land to fund the new lab, which will be next to the St. Pancras train station, which has connections to the rest of Europe.

In a statement today, Wellcome Trust Director Mark Walport welcomed the council approval, saying: “UKCMRI will be a world leading institute tackling the most challenging issues facing our health and wellbeing today.” The new development, he added, is “strategically positioned amidst the cluster of outstanding research and medical institutions in Camden and close to the international transport hub at King’s Cross and St. Pancras.”

The center, set to begin its work in 2016, has outlined a number of strategies to engage the public in its work and will provide educational benefits to schools locally and nationally. “We look forward to working closely with the Council and the local community to develop the Institute, which will complement the regeneration of the local area and bring to it tangible benefits,” Walport states.

:: Read original here ::